Pub Date : 2019-01-01DOI: 10.17925/use.2019.15.2.77
Y. Daneshbod, S. Shirian, H. Gharib
{"title":"Molecular Testing in Thyroid Practice","authors":"Y. Daneshbod, S. Shirian, H. Gharib","doi":"10.17925/use.2019.15.2.77","DOIUrl":"https://doi.org/10.17925/use.2019.15.2.77","url":null,"abstract":"<p />","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67604064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.17925/USE.2019.15.1.15
C. Greenbaum
{"title":"Disease-modifying Therapies for the Prevention of Type 1 Diabetes","authors":"C. Greenbaum","doi":"10.17925/USE.2019.15.1.15","DOIUrl":"https://doi.org/10.17925/USE.2019.15.1.15","url":null,"abstract":"<p />","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67603334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.17925/USE.2019.15.1.27
J. Ved, K. Paul, S. Kalra
{"title":"Vasculo-metabolic Axis in Type 2 Diabetes Mellitus—Abductive Reasoning from Sodium-glucose Cotransporter 2-inhibitor Evidence","authors":"J. Ved, K. Paul, S. Kalra","doi":"10.17925/USE.2019.15.1.27","DOIUrl":"https://doi.org/10.17925/USE.2019.15.1.27","url":null,"abstract":"<p />","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67603410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-01-01DOI: 10.17925/USE.2018.14.1.30
S. Kalra, M. Bathla, D. Khandelwal
This communication describes the need for a salutogenic (health-promoting) attitude in our thoughts, communication, and action while managing diabetes. Such an approach is more patient-friendly than a pathogenesis or disease-based framework of medicine. Keeping this in mind, it could be more appropriate to measure positive aspects of life with diabetes, such as coping skills, rather than diabetes distress, which has a negative connotation. This article describes the utility of the GlucoCoper in screening, diagnosing, and managing diabetes distress.
{"title":"The GlucoCoper—A Salutogenic Approach to Diabetes Distress","authors":"S. Kalra, M. Bathla, D. Khandelwal","doi":"10.17925/USE.2018.14.1.30","DOIUrl":"https://doi.org/10.17925/USE.2018.14.1.30","url":null,"abstract":"This communication describes the need for a salutogenic (health-promoting) attitude in our thoughts, communication, and action while managing diabetes. Such an approach is more patient-friendly than a pathogenesis or disease-based framework of medicine. Keeping this in mind, it could be more appropriate to measure positive aspects of life with diabetes, such as coping skills, rather than diabetes distress, which has a negative connotation. This article describes the utility of the GlucoCoper in screening, diagnosing, and managing diabetes distress.","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":"14 1","pages":"30"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67603516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-01-01DOI: 10.17925/USE.2018.14.2.51
S. Lafranchi
Received: July 19, 2018 Published Online: September 12, 2018 Citation: US Endocrinology, 2018;14(2):51–3. Corresponding Author: Stephen H LaFranchi, Department of Pediatrics [CDRCP], Oregon Health & Science University, 707 SW Gaines St, Portland, Oregon, US. E: lafrancs@ohsu.edu T his interview explores current controversies in the management of hypothyroidism in children. Newborn screening programs have allowed early detection and treatment of babies with congenital hypothyroidism, but some programs do not detect cases with delayed thyroidstimulating hormone (TSH) elevation and most do not detect congenital central hypothyroidism. Lack of harmonization of TSH cut-offs means that some programs do not detect milder cases of congenital hypothyroidism. Detection of such mild cases is controversial as most patients have transient hypothyroidism and the benefit of treatment is not proven. The most common disorder of thyroid function in children is subclinical hypothyroidism—many of these cases represent TSH assay artifacts or are associated with obesity, but some will progress to overt hypothyroidism. Some patients/parents are not happy with levothyroxine treatment alone, which raises the consideration of combination thyroxine and triiodothyronine (T4 and T3) treatment. Further research, including randomized clinical trials, is required to resolve these issues.
{"title":"Managing Hypothyroidism in Pediatric Patients","authors":"S. Lafranchi","doi":"10.17925/USE.2018.14.2.51","DOIUrl":"https://doi.org/10.17925/USE.2018.14.2.51","url":null,"abstract":"Received: July 19, 2018 Published Online: September 12, 2018 Citation: US Endocrinology, 2018;14(2):51–3. Corresponding Author: Stephen H LaFranchi, Department of Pediatrics [CDRCP], Oregon Health & Science University, 707 SW Gaines St, Portland, Oregon, US. E: lafrancs@ohsu.edu T his interview explores current controversies in the management of hypothyroidism in children. Newborn screening programs have allowed early detection and treatment of babies with congenital hypothyroidism, but some programs do not detect cases with delayed thyroidstimulating hormone (TSH) elevation and most do not detect congenital central hypothyroidism. Lack of harmonization of TSH cut-offs means that some programs do not detect milder cases of congenital hypothyroidism. Detection of such mild cases is controversial as most patients have transient hypothyroidism and the benefit of treatment is not proven. The most common disorder of thyroid function in children is subclinical hypothyroidism—many of these cases represent TSH assay artifacts or are associated with obesity, but some will progress to overt hypothyroidism. Some patients/parents are not happy with levothyroxine treatment alone, which raises the consideration of combination thyroxine and triiodothyronine (T4 and T3) treatment. Further research, including randomized clinical trials, is required to resolve these issues.","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":"14 1","pages":"51"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67603573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-01-01DOI: 10.17925/USE.2018.14.1.20
M. Marcovecchio
Support: No funding was received in the publication of this article. The needs of pediatric patients with diabetes differ from those of adults. Challenges include growth and development, and care outside of the home, such as in the school setting. In addition, in type 2 diabetes, there are fewer treatment options for pediatric patients; while recent years have seen the approval of many glucose-lowering drugs for adults, only metformin and insulin are approved in patients aged under 18 years. In an expert interview, M Loredana Marcovecchio, of the University of Cambridge, UK, discusses recent advances and remaining challenges in the treatment of pediatric patients with both type 1 and type 2 diabetes.
{"title":"Treatment Options for Pediatric Diabetes","authors":"M. Marcovecchio","doi":"10.17925/USE.2018.14.1.20","DOIUrl":"https://doi.org/10.17925/USE.2018.14.1.20","url":null,"abstract":"Support: No funding was received in the publication of this article. The needs of pediatric patients with diabetes differ from those of adults. Challenges include growth and development, and care outside of the home, such as in the school setting. In addition, in type 2 diabetes, there are fewer treatment options for pediatric patients; while recent years have seen the approval of many glucose-lowering drugs for adults, only metformin and insulin are approved in patients aged under 18 years. In an expert interview, M Loredana Marcovecchio, of the University of Cambridge, UK, discusses recent advances and remaining challenges in the treatment of pediatric patients with both type 1 and type 2 diabetes.","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":"14 1","pages":"20"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67603442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-01-01DOI: 10.17925/USE.2018.14.1.35
L. Gupta, Swarnima Prakash, D. Khandelwal, B. Kalra, S. Kalra
1. Department of Food & Nutrition, Lady Irwin College, Delhi University, New Delhi, India; 2. Department of Dietetics, Maharaja Agrasen Hospital, Punjabi Bagh, New Delhi, India; 3. Department of Endocrinology & Diabetes, Maharaja Agrasen Hospital, Punjabi Bagh, New Delhi, India; 4. Department of Gynecology, Bharti Hospital, Karnal, Haryana, India; 5. Department of Endocrinology, Bharti Hospital, Karnal, Haryana, India
{"title":"Diabetes and Female Sexual Dysfunction","authors":"L. Gupta, Swarnima Prakash, D. Khandelwal, B. Kalra, S. Kalra","doi":"10.17925/USE.2018.14.1.35","DOIUrl":"https://doi.org/10.17925/USE.2018.14.1.35","url":null,"abstract":"1. Department of Food & Nutrition, Lady Irwin College, Delhi University, New Delhi, India; 2. Department of Dietetics, Maharaja Agrasen Hospital, Punjabi Bagh, New Delhi, India; 3. Department of Endocrinology & Diabetes, Maharaja Agrasen Hospital, Punjabi Bagh, New Delhi, India; 4. Department of Gynecology, Bharti Hospital, Karnal, Haryana, India; 5. Department of Endocrinology, Bharti Hospital, Karnal, Haryana, India","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":"14 1","pages":"35"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67603566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-01-01DOI: 10.17925/USE.2018.14.2.87
D. Dutta, D. Khandelwal, S. Chittawar, S. Aggarwal, S. Bhattacharya, Vineet Surana, R. Singla, S. Kalra, Dwarka New Delhi India Kalpravriksh Superspeciality Clinic
1. Department of Endocrinology, Diabetology & Metabolic Disorders, Venkateshwar Hospitals, Dwarka, New Delhi, India; 2. Department of Endocrinology, Maharaja Agrasen Hospital, New Delhi, India; 3. Division of Endocrinology, Department of Medicine, Gandhi Medical College (GMC) and Hamidia Hospital, Bhopal, India; 4. Division of Endocrinology, Department of Medicine, Pandit Bhagwat Dayal Sharma Postgraduate Institute of Medical Sciences (PGIMS), Rohtak, India; 5. Department of Endocrinology, Max Superspeciality Hospital, Patparganj, New Delhi, India; 6. Department of Endocrinology & Diabetology, Manipal Hospitals, Dwarka, New Delhi, India; 7. Kalpravriksh Superspeciality Clinic, Dwarka, New Delhi, India; 8. Department of Endocrinology, Bharti Research Institute of Diabetes & Endocrinology (BRIDE), Karnal, India
{"title":"Bone Health Clinical Practice in India—Concern Regarding Vitamin D Toxicity","authors":"D. Dutta, D. Khandelwal, S. Chittawar, S. Aggarwal, S. Bhattacharya, Vineet Surana, R. Singla, S. Kalra, Dwarka New Delhi India Kalpravriksh Superspeciality Clinic","doi":"10.17925/USE.2018.14.2.87","DOIUrl":"https://doi.org/10.17925/USE.2018.14.2.87","url":null,"abstract":"1. Department of Endocrinology, Diabetology & Metabolic Disorders, Venkateshwar Hospitals, Dwarka, New Delhi, India; 2. Department of Endocrinology, Maharaja Agrasen Hospital, New Delhi, India; 3. Division of Endocrinology, Department of Medicine, Gandhi Medical College (GMC) and Hamidia Hospital, Bhopal, India; 4. Division of Endocrinology, Department of Medicine, Pandit Bhagwat Dayal Sharma Postgraduate Institute of Medical Sciences (PGIMS), Rohtak, India; 5. Department of Endocrinology, Max Superspeciality Hospital, Patparganj, New Delhi, India; 6. Department of Endocrinology & Diabetology, Manipal Hospitals, Dwarka, New Delhi, India; 7. Kalpravriksh Superspeciality Clinic, Dwarka, New Delhi, India; 8. Department of Endocrinology, Bharti Research Institute of Diabetes & Endocrinology (BRIDE), Karnal, India","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":"14 1","pages":"87"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67603255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-01-01DOI: 10.17925/USE.2018.14.1.13
C. Lardinois
{"title":"Expert Perspective on the American Diabetes Association Dietary Guidelines for Patients with Diabetes","authors":"C. Lardinois","doi":"10.17925/USE.2018.14.1.13","DOIUrl":"https://doi.org/10.17925/USE.2018.14.1.13","url":null,"abstract":"","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":"14 1","pages":"13"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67603311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：